WITec opens new regional headquarters in Singapore
WITec GmbH announced its further expansion into the Asian-Pacific markets with the opening of a new office in Singapore. In this step, WITec advances its strategy of being closer to the market and strengthening its position in the Asian-Pacific region. The decision to launch the new operations in Singapore will accelerate WITec’s growth and reflects the philosophy of better serving the worldwide customer base.
Located in the “German Centre Singapore”, the new office will provide valuable support to the numerous sales and service activities of the regional distributors. Under the leadership of Matthias Kress, WITec Director Sales Asia, the new Singapore office aims to further establish WITec high-resolution microscope systems in the scientific community of the region. The new office is located at:
“As the Asian-Pacific scientific market offers huge potential for our microscope systems and already shows one of the biggest growth rates, the timing to establish our own regional headquarters is ideal” says new Managing Director Matthias Kress.
“The decision to launch the operations in Singapore is a reflection of an increased commitment to the Asian-Pacific market in general” Kress continues. As for the reasons why Singapore was chosen by WITec, Kress comments: “As a regional hub for Asia, Singapore is the perfect choice for the location.”
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

A 'bio-refinery': using the chemistry of willow trees to treat municipal wastewater - Millions of litres of primary municipal wastewater can be treated sustainably using fast-growing willow trees while also producing renewable bioenergy and ‘green’ chemicals
Lymphoma overrides a key protein's quadruple locks
TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg cells in Crohn’s disease
Two known chemotherapy agents effectively target breast cancer stem cells
Psilocybin eases existential anxiety in people with life-threatening cancer

Anti-cancer drug brewed from reprogrammed yeast - Engineered yeast cells can synthetically produce the essential cancer medicine vinblastine, an international team of scientists proved

Study reveals how 'forever chemicals' may impact heart health in older women - "Our results show you can’t lump all PFAS together"
Neovacs achieves key clinical milestones
Cougar Biotechnology Announces Initiation of Phase I/II Trial of CB7630 (Abiraterone Acetate) in Advanced Breast Cancer Patients
Stratagene Acquires Rights to microRNA Sequences - Co-Exclusive License Provides Access to More Than 150 microRNA Sequences for the Development, Manufacture and Sale of Molecular Diagnostic Kits
